LT4073097T - Nauji insulino analogai ir jų naudojimas - Google Patents

Nauji insulino analogai ir jų naudojimas

Info

Publication number
LT4073097T
LT4073097T LTEPPCT/EP2020/085541T LTEP2020085541T LT4073097T LT 4073097 T LT4073097 T LT 4073097T LT EP2020085541 T LTEP2020085541 T LT EP2020085541T LT 4073097 T LT4073097 T LT 4073097T
Authority
LT
Lithuania
Prior art keywords
insulin analogues
novel insulin
novel
analogues
insulin
Prior art date
Application number
LTEPPCT/EP2020/085541T
Other languages
English (en)
Inventor
Frantisek Hubalek
Mathias Norrman
Helle Olsen
Peter Madsen
Thomas Kjeldsen
Jeppe Sturis
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of LT4073097T publication Critical patent/LT4073097T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEPPCT/EP2020/085541T 2019-12-11 2020-12-10 Nauji insulino analogai ir jų naudojimas LT4073097T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19215315 2019-12-11
PCT/EP2020/085541 WO2021116292A1 (en) 2019-12-11 2020-12-10 Novel insulin analogues and uses thereof

Publications (1)

Publication Number Publication Date
LT4073097T true LT4073097T (lt) 2024-09-10

Family

ID=68886882

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2020/085541T LT4073097T (lt) 2019-12-11 2020-12-10 Nauji insulino analogai ir jų naudojimas

Country Status (29)

Country Link
US (3) US11498951B2 (lt)
EP (2) EP4073097B1 (lt)
JP (2) JP6995284B2 (lt)
KR (1) KR102427426B1 (lt)
CN (1) CN114787184A (lt)
AR (1) AR120717A1 (lt)
AU (1) AU2020402135A1 (lt)
BR (1) BR112022009510A2 (lt)
CA (1) CA3159114A1 (lt)
CL (1) CL2023000086A1 (lt)
CO (1) CO2022007273A2 (lt)
DK (1) DK4073097T3 (lt)
ES (1) ES2985989T3 (lt)
FI (1) FI4073097T3 (lt)
HR (1) HRP20241042T1 (lt)
HU (1) HUE067827T2 (lt)
IL (2) IL319162A (lt)
LT (1) LT4073097T (lt)
MA (1) MA58093B1 (lt)
MX (2) MX2022006251A (lt)
MY (1) MY208364A (lt)
PE (1) PE20221260A1 (lt)
PH (1) PH12022551094A1 (lt)
PL (1) PL4073097T3 (lt)
PT (1) PT4073097T (lt)
RS (1) RS65822B1 (lt)
SI (1) SI4073097T1 (lt)
TW (1) TWI773009B (lt)
WO (1) WO2021116292A1 (lt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2908373T3 (es) 2015-08-25 2022-04-28 Novo Nordisk As Nuevos derivados de insulina y los usos médicos de los mismos
DK4073097T3 (da) * 2019-12-11 2024-08-19 Novo Nordisk As Nye insulinanaloger og anvendelser heraf
KR20230057686A (ko) 2021-10-22 2023-05-02 주식회사 엘지에너지솔루션 캡 어셈블리 및 이를 포함하는 이차 전지

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
JP3122128B2 (ja) 1989-12-21 2001-01-09 ノボ ノルディスク アクティーゼルスカブ ペプチド製剤
EP1132404A3 (en) 1993-09-17 2002-03-27 Novo Nordisk A/S Acylated insulin
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
IL114160A (en) 1994-06-17 2006-12-31 Novo Nordisk As Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
US5922678A (en) 1996-06-28 1999-07-13 Eli Lilly And Company Methods for treating diabetes
ES2258797T3 (es) 1996-12-20 2006-09-01 Novo Nordisk A/S Proteinas con extension n-terminal expresadas en la levadura.
EP1005490B1 (en) 1997-03-20 2006-03-29 Novo Nordisk A/S Zinc free insulin crystals for use in pulmonary compositions
JP2001521006A (ja) 1997-10-24 2001-11-06 イーライ・リリー・アンド・カンパニー 不溶性インシュリン組成物
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
EP1692168B1 (en) 2003-12-03 2011-07-20 Novo Nordisk A/S Single-chain insulin
JP2008533100A (ja) 2005-03-18 2008-08-21 ノボ ノルディスク アクティーゼルスカブ Ｐｅｇ化された単鎖インスリン
DE602007009496D1 (de) 2006-02-27 2010-11-11 Novo Nordisk As Insulinderivate
JP2009530243A (ja) 2006-03-13 2009-08-27 ノボ・ノルデイスク・エー／エス アシル化単鎖インスリン
ITRG20070003A1 (it) 2007-07-17 2009-01-18 Salvatore Lucifora Metodo e sistema informatico per analizzare le prestazioni e dimensionare una cella underlay/overlay di un sistema di telecomunicazione cellulare
JP5710253B2 (ja) 2007-08-13 2015-04-30 ノボ・ノルデイスク・エー／エス 速効型インスリンアナログ
US9150633B2 (en) 2007-08-15 2015-10-06 Novo Nordisk A/S Insulin analogues with an acyl and alkylene glycol moiety
JP5721432B2 (ja) 2007-08-15 2015-05-20 ノボ・ノルデイスク・エー／エス アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン
WO2009112583A2 (en) 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
CN102065903B (zh) 2008-04-01 2015-02-18 诺沃-诺迪斯克有限公司 胰岛素清蛋白缀合物
EP2448962B1 (en) 2009-06-30 2016-10-19 Novo Nordisk A/S Insulin derivatives
ES2552401T3 (es) 2009-11-02 2015-11-27 Novo Nordisk A/S Solución farmacéutica de albúmina unida no covalentemente e insulina acilada
JP5973427B2 (ja) 2010-06-23 2016-08-23 ノヴォ ノルディスク アー／エス 追加のジスルフィド結合を含有するインスリン類似体
EP2598522A4 (en) 2010-07-28 2014-11-12 Smartcells Inc RECOMBINANT LKTINE, BINDING POINT MODIFIED LECTIN AND APPLICATIONS THEREOF
WO2012049307A2 (en) 2010-10-15 2012-04-19 Novo Nordisk A/S Novel n-terminally modified insulin derivatives
CN103596584B (zh) 2011-06-15 2016-12-14 诺沃—诺迪斯克有限公司 多取代的胰岛素
KR20150021011A (ko) 2011-10-27 2015-02-27 케이스 웨스턴 리저브 유니버시티 초고도 농축된, 속효성 인슐린 유사체 제형
KR20140104994A (ko) 2011-12-15 2014-08-29 샹하이 헨그루이 파마수티컬 컴퍼니 리미티드 인간 인슐린 유사체 및 이의 아실화 유도체
JP6538645B2 (ja) 2013-03-14 2019-07-03 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ インスリン‐インクレチン複合物
KR20160065930A (ko) 2013-10-04 2016-06-09 머크 샤프 앤드 돔 코포레이션 글루코스-반응성 인슐린 접합체
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
US20190010206A1 (en) 2015-08-25 2019-01-10 Novo Nordisk A/S Novel Insulin Derivatives and the Medical Uses Hereof
ES2908373T3 (es) 2015-08-25 2022-04-28 Novo Nordisk As Nuevos derivados de insulina y los usos médicos de los mismos
CN105440125B (zh) 2015-11-25 2019-09-24 华润昂德生物药业有限公司 地特胰岛素或其类似物的制备方法
US11413352B2 (en) 2017-12-18 2022-08-16 Merck, Sharp & Dohme LLC Conjugate based systems for controlled insulin delivery
DK4073097T3 (da) 2019-12-11 2024-08-19 Novo Nordisk As Nye insulinanaloger og anvendelser heraf

Also Published As

Publication number Publication date
US12122818B2 (en) 2024-10-22
IL292762A (en) 2022-07-01
AU2020402135A1 (en) 2022-06-02
FI4073097T3 (fi) 2024-08-13
KR20210141748A (ko) 2021-11-23
DK4073097T3 (da) 2024-08-19
EP4073097B1 (en) 2024-07-03
HRP20241042T1 (hr) 2024-11-08
US20230192801A1 (en) 2023-06-22
PT4073097T (pt) 2024-08-16
EP4480492A2 (en) 2024-12-25
SI4073097T1 (sl) 2024-09-30
TW202136289A (zh) 2021-10-01
TWI773009B (zh) 2022-08-01
US20240141011A1 (en) 2024-05-02
IL292762B1 (en) 2025-06-01
CL2023000086A1 (es) 2023-08-04
JP6995284B2 (ja) 2022-01-14
CA3159114A1 (en) 2021-06-17
EP4480492A3 (en) 2025-03-19
BR112022009510A2 (pt) 2022-08-16
MX2023000398A (es) 2023-02-02
US11498951B2 (en) 2022-11-15
KR102427426B1 (ko) 2022-08-01
MA58093B1 (fr) 2024-09-30
IL319162A (en) 2025-04-01
US12152063B2 (en) 2024-11-26
JP2021119193A (ja) 2021-08-12
PH12022551094A1 (en) 2024-06-24
CN114787184A (zh) 2022-07-22
MY208364A (en) 2025-05-01
WO2021116292A1 (en) 2021-06-17
EP4073097A1 (en) 2022-10-19
AR120717A1 (es) 2022-03-09
PE20221260A1 (es) 2022-08-16
PL4073097T3 (pl) 2024-10-28
US20210179685A1 (en) 2021-06-17
JP2021091685A (ja) 2021-06-17
MX2022006251A (es) 2022-06-22
RS65822B1 (sr) 2024-09-30
HUE067827T2 (hu) 2024-11-28
ES2985989T3 (es) 2024-11-08
IL292762B2 (en) 2025-10-01
CO2022007273A2 (es) 2022-08-19

Similar Documents

Publication Publication Date Title
IL294052B2 (en) Fluoroalkyl oxadiazoles and their uses
IL285177A (en) compounds and their use
IL277483A (en) New anti-GLP-1 analogs
IL286497A (en) compounds and their use
ZA201802017B (en) Novel insulin analogs and use thereof
CA187784S (en) Syringe
IL272394A (en) Similar organs based on insulin with acyl and their uses
IL283395A (en) Arylmethylureas and substituted heteroarylmethylureas, their analogues and their uses
IL291499A (en) Azaquinoline compounds and their uses
HUE068308T2 (hu) Tieniloxazolonok és analógok
SG11202108079RA (en) Compounds and uses thereof
ZA201907833B (en) Heteroarylphenylaminoquinolines and analogues
GB2600592B (en) Polypeptide and use thereof
GB201711749D0 (en) Cyclosporin analogues and uses thereof
IL287503A (en) Thio-semicarbazide compounds and their use
LT4073097T (lt) Nauji insulino analogai ir jų naudojimas
IL284764A (en) compounds and their uses
IL253600A0 (en) Insulin analogs and preparations containing them
EP3590519A4 (en) GLP-1 SECRETAGOGUE AND COMPOSITION
EP3947418C0 (en) PEPTIDES AND THEIR USE
ZA202201239B (en) Aminothiolester compounds and uses thereof
GB2585141B (en) Syringe
HK40026613A (en) Novel acylated insulin analogues and uses thereof
ZA202005315B (en) Novel promoter and use thereof
IL284666A (en) New peptides and their uses